PUBLISHER: The Business Research Company | PRODUCT CODE: 2131950
PUBLISHER: The Business Research Company | PRODUCT CODE: 2131950
Clinical-grade wearable remote patient monitoring refers to the use of medically approved wearable devices that continuously collect and transmit patient health information, such as heart rate, oxygen levels, and electrocardiogram (ECG) readings, beyond traditional healthcare settings. These systems are developed to comply with regulatory and clinical requirements, allowing healthcare providers to remotely monitor patient conditions in real time and support timely diagnosis and treatment.
The primary device types of clinical-grade wearable remote patient monitoring include cardiac monitors, continuous glucose monitors, respiratory monitors, neurological monitors, and multi-parameter patches. Cardiac monitors refer to wearable medical devices that continuously monitor heart activity and transmit clinical-grade physiological data to enable remote patient assessment and timely medical intervention. These devices utilize connectivity technologies including Bluetooth, cellular, wireless fidelity, and near-field communication and are designed for adult patients, geriatric patients, and pediatric patients. The various applications include chronic disease management, post-acute care monitoring, elderly care monitoring, fitness and preventive healthcare, remote intensive care unit monitoring, and medication adherence monitoring, and they are used by end users such as hospitals and health systems, home care settings, ambulatory surgical centers, long-term care facilities, specialty clinics, and rehabilitation centers.
Tariffs are influencing the clinical-grade wearable remote patient monitoring market by increasing the cost of imported wearable sensors, semiconductor components, medical-grade electronics, and connectivity modules required for device manufacturing. This is affecting production expenses and supply chain efficiency, particularly in regions dependent on imported healthcare technology components such as North America, Europe, and Asia-Pacific. Device segments, including cardiac monitors, continuous glucose monitors, and multiparameter patches, are experiencing the greatest impact due to their dependence on specialized components and advanced manufacturing processes. However, tariffs are also encouraging local production, regional supply chain diversification, and investments in domestic medical device manufacturing capabilities.
The clinical-grade wearable remote patient monitoring market research report is one of a series of new reports from The Business Research Company that provides clinical-grade wearable remote patient monitoring market statistics, including clinical-grade wearable remote patient monitoring industry global market size, regional shares, competitors with a clinical-grade wearable remote patient monitoring market share, detailed clinical-grade wearable remote patient monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the clinical-grade wearable remote patient monitoring industry. This clinical-grade wearable remote patient monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The clinical-grade wearable remote patient monitoring market size has grown exponentially in recent years. It will grow from $123.21 billion in 2025 to $149.24 billion in 2026 at a compound annual growth rate (CAGR) of 21.1%. The growth during the historic period was driven by increasing prevalence of chronic diseases, rising adoption of remote healthcare services, growing demand for continuous health monitoring, expansion of telemedicine infrastructure, and increasing healthcare focus on preventive care.
The clinical-grade wearable remote patient monitoring market size is expected to see exponential growth in the next few years. It will grow to $323.75 billion in 2030 at a compound annual growth rate (CAGR) of 21.4%. The growth during the forecast period can be attributed to growing demand for personalized healthcare monitoring, increasing adoption of home-based patient care solutions, rising investments in wearable medical technology, expanding use of real-time health analytics, and increasing need for cost-efficient healthcare delivery models. Major trends during the forecast period include increasing adoption of regulatory-compliant wearable health monitoring devices, growing demand for real-time patient health data transmission, rising integration of advanced biosensors in medical wearable devices, expansion of remote patient monitoring programs across healthcare systems, and increasing development of compact multi-parameter wearable monitoring solutions.
The growing adoption of telehealth is expected to drive the growth of the clinical-grade wearable remote patient monitoring market in the coming years. Telehealth refers to the provision of healthcare services and clinical information through digital communication technologies, including video consultations, mobile applications, and remote monitoring systems, allowing patients to access healthcare without requiring physical visits. The increasing adoption of telehealth is driven by the rising demand for convenient and accessible healthcare solutions, as virtual care allows patients to receive medical assistance remotely without frequent hospital appointments. Clinical-grade wearable remote patient monitoring supports telehealth by facilitating continuous and real-time collection of physiological data outside traditional healthcare environments, improving remote diagnosis, personalized treatment planning, and proactive patient care management. For example, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, national telehealth utilization increased by 7.3% in 2023, growing from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, growing telehealth adoption is driving the growth of the clinical-grade wearable remote patient monitoring market.
Major companies operating in the clinical-grade wearable remote patient monitoring market are concentrating on developing advanced platforms, such as multi-sensor remote patient monitoring (RPM) platforms, to enhance real-time patient monitoring, enable decentralized healthcare delivery, and improve clinical decision-making. A multi-sensor remote patient monitoring (RPM) platform is a digital healthcare solution that combines information from multiple wearable devices or connected sensors to continuously monitor a patient's vital signs and health parameters in real time outside healthcare facilities for remote evaluation and care management. For instance, in January 2024, Blue Spark Technologies Inc., a US-based digital health technology company, launched VitalTraq, an advanced multi-vital remote patient monitoring platform designed to enhance continuous patient monitoring and support decentralized clinical trials. The platform combines AI-powered contactless remote photoplethysmography (rPPG) facial scanning technology with the company's TempTraq wearable temperature monitoring patch to monitor vital signs, including heart rate, blood pressure, respiratory rate, heart rate variability, and continuous body temperature, through a single mobile application. The HIPAA-compliant solution also provides cloud-based connectivity and a web-based monitoring dashboard, allowing healthcare providers and researchers to efficiently access real-time patient health information while minimizing dependence on multiple monitoring devices.
In March 2026, Vitalist Inc., a US-based wearable technology and software company, acquired Somatix for an undisclosed amount. Through this acquisition, Vitalist Inc. aims to enhance its medical-grade AI capabilities and expand its global remote patient monitoring ecosystem by incorporating Somatix's behavioral sensing and wearable intelligence technologies into its existing VitalOS platform to improve real-time clinical insights and patient engagement. Somatix Inc. is a US-based company that offers clinical-grade wearable remote patient monitoring (RPM) solutions.
Major companies operating in the clinical-grade wearable remote patient monitoring market are Abbott, Adherium Limited, Aktiia SA, Biobeat Technologies Ltd., BioIntelliSense Inc., Cloud DX Inc., Dexcom, Empatica Inc., iRhythm, InfoBionic Inc., Isansys Lifecare Ltd., Lief Therapeutics Inc., Masimo, MediBioSense Ltd., Medtronic, Nanowear Inc., Shimmer Research Ltd., SmartCardia SA, Tenovi Inc., TytoCare Ltd., VitalConnect Inc., VivaLNK Inc.
North America was the dominating region in the clinical-grade wearable remote patient monitoring market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the clinical-grade wearable remote patient monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the clinical-grade wearable remote patient monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The clinical-grade wearable remote patient monitoring market consists of revenues earned by entities by providing services such as real-time health data collection and transmission, continuous patient surveillance, chronic disease management, telehealth integration, and alert and notification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical-grade wearable remote patient monitoring market also includes sales of smart electrocardiogram monitors, wearable blood pressure monitors, pulse oximeters, cardiac patches, biosensor-enabled smartwatches, and respiratory monitoring wearables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clinical-Grade Wearable Remote Patient Monitoring Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses clinical-grade wearable remote patient monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for clinical-grade wearable remote patient monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical-grade wearable remote patient monitoring market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.